Sign In
Buy GLV
$6.29
+0 (+0%)
At Close: Jul 31, 2026
Stocks Which Set New 52-Week Low Yesterday, Thurs., Dec. 13, 2018
12:00am, Friday, 14'th Dec 2018Stocks Which Set New 52-Week Low The Last Trading Session, Wed., Nov. 21, 2018
02:09pm, Friday, 23'rd Nov 2018Stocks Which Set New 52-Week Low Yesterday, Tues., Nov. 20, 2018
12:00am, Wednesday, 21'st Nov 2018Stocks Which Set New 52-Week Low Yesterday, Mon., Nov. 19, 2018
12:00am, Tuesday, 20'th Nov 2018Stocks Which Set New 52-Week Low Yesterday, October 23rd
12:00am, Wednesday, 24'th Oct 2018Stocks Which Set New 52-Week Low Yesterday, October 10th
01:11pm, Thursday, 11'th Oct 2018Stocks Which Set New 52-Week Low Yesterday, September 26th
12:00am, Thursday, 27'th Sep 2018Stocks Which Set New 52-Week Low Yesterday, September 25th
12:00am, Wednesday, 26'th Sep 2018Apellis Pharmaceuticals Raises $60M in Series E Financing |FinSMEs
01:16pm, Thursday, 10'th Aug 2017
Apellis Pharmaceuticals, Inc., a Lousiville, Ky.-based clinical-stage biopharmaceutical company developing a platform of novel therapeutic compounds for the treatment of autoimmune diseases, closed a
Sienna Biopharmaceuticals Completes $40M Series B Financing |FinSMEs
02:40pm, Monday, 24'th Apr 2017
Sienna Biopharmaceuticals, Inc., a Westlake Village, Calif.-based clinical stage medical dermatology and aesthetics company, completed a $40m Series B financing. The round was led by existing investor
